Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Article in English | MEDLINE | ID: mdl-36674186

ABSTRACT

This study investigates the feasibility of an accompanied 5-day hiking tour (Way of St. James) for type 2 diabetes mellitus (T2DM) patients and its impact on their quality of life/well-being, diabetes distress and glucose profile. Twenty-three T2DM patients (with and without insulin therapy) participated in the study. The 120 km pilgrimage (from Ferrol to Santiago de Compostela, Spain) was accompanied by three physicians, two diabetes counselors and one sports scientist. Quality of life/well-being was assessed by the World Health Organization's (WHO)-5 questionnaire, and diabetes distress was evaluated based on the Problem Areas in Diabetes (PAID) scale. The glucose levels of six insulin-treated patients were measured using continuous glucose monitoring (CGM) devices, considering that insulin-treated patients can be at increased risk of exercise-induced hypoglycemia. A significant improvement in quality of life/well-being was reported (p < 0.001), while diabetes distress did not change significantly (p = 0.203). Only two of the six insulin-treated patients showed moderate hypoglycemic episodes between 0.97% and 5.21% time below range per day, with glucose levels between 53−70 mg/dL. Hiking tours such as the one organized for this study can improve quality of life/well-being without increasing diabetes distress and are considered relatively safe for T2DM patients, even for those being treated with insulin.


Subject(s)
Diabetes Mellitus, Type 2 , Hypoglycemia , Humans , Diabetes Mellitus, Type 2/drug therapy , Diabetes Mellitus, Type 2/complications , Hypoglycemic Agents , Feasibility Studies , Glucose , Blood Glucose Self-Monitoring , Quality of Life , Blood Glucose/analysis , Insulin/therapeutic use , Hypoglycemia/complications
2.
Biotechnol Bioeng ; 95(6): 1023-31, 2006 Dec 20.
Article in English | MEDLINE | ID: mdl-16732593

ABSTRACT

Autolysis of riboflavin-producing B. subtilis can be induced by pH, lack of carbon source, and the buffer system. Stress factors like temperature shift or oxygen dearth enhance the autolysis process. After cultivation of a riboflavin-producing strain, the pH of the whole culture broth was adjusted to 6.5-7.5. At a temperature of 40 degrees C, autolysis started after 1 h. Adding a defined amount of commercially available endo- and exo-proteases enhanced both auto- and proteo-lysis. Optimization of endo- and exo-protease concentrations and of the time increased the degree of proteolysis. Additionally, the amount of DNA and Protein trapped in the riboflavin crystals could be significantly reduced by autolysis. After autolysis, the cultivation broth was centrifuged and the supernatant was cross-flow filtrated with a cut off of 10 kDa. Using this autolysate instead of yeast extract as a medium component for riboflavin production with B. subtilis, a riboflavin yield of 77% was obtained in comparison with the standard cultivation on yeast extract.


Subject(s)
Bacillus subtilis/metabolism , Biomass , Biotechnology/methods , Riboflavin/biosynthesis , Riboflavin/chemistry , Bioreactors , Carbon/chemistry , Culture Media/metabolism , Culture Media/pharmacology , Fermentation , Flavin Mononucleotide/chemistry , Genome, Bacterial , Hydrogen-Ion Concentration , Peptide Hydrolases/chemistry , Sodium Hydroxide/chemistry , Temperature , Time Factors
3.
J Biol Chem ; 280(26): 25258-66, 2005 Jul 01.
Article in English | MEDLINE | ID: mdl-15870074

ABSTRACT

Pituitary adenylyl cyclase-activating polypeptide 38 (PACAP38) plays an important role in the proliferation and differentiation of neural cells. In the present study, we have investigated how PACAP38 inhibits the proliferation of cultured neocortical astroglial cells. When applied to synchronized cells during the G(1) phase of the cell cycle, PACAP38 diminished the subsequent nuclear uptake of bromodeoxyuridine. When applied for 2 days, it reduced the cell number. PACAP38 did not exert its antiproliferative effect by activating protein kinase A. It also did not reduce the activity of mitogen-activated protein kinases essential for G(1) phase progression. Instead, PACAP38 acted on a member of the Rho family of small GTPases. It reduced the activity of RhoA as was shown with a Rhotekin pull-down assay. The decrease in endogenous RhoA activity induced by treatment of the cells with C3 exotoxin or by expression of dominant negative RhoA also reduced the nuclear uptake of bromodeoxyuridine. In contrast, expression of constitutively active RhoA prevented the effect of PACAP38. Our data show a novel signal transduction pathway by which the neuropeptide influences cell proliferation.


Subject(s)
Astrocytes/cytology , Nerve Growth Factors/physiology , Neuropeptides/physiology , Neurotransmitter Agents/physiology , rhoA GTP-Binding Protein/metabolism , Actins/chemistry , Adenoviridae/genetics , Animals , Animals, Newborn , Astrocytes/metabolism , Bromodeoxyuridine/pharmacology , Cell Cycle , Cell Line , Cell Nucleus/metabolism , Cell Proliferation , Cyclic AMP-Dependent Protein Kinases/metabolism , Enzyme Inhibitors/pharmacology , G1 Phase , GTP Phosphohydrolases/chemistry , GTP-Binding Proteins , Genes, Dominant , Glutathione Transferase/metabolism , Green Fluorescent Proteins/metabolism , Intracellular Signaling Peptides and Proteins/chemistry , MAP Kinase Signaling System , Microscopy, Fluorescence , Nerve Growth Factors/metabolism , Neuropeptides/metabolism , Neurotransmitter Agents/metabolism , Peptides/chemistry , Pituitary Adenylate Cyclase-Activating Polypeptide , RNA, Messenger/metabolism , Rats , Rats, Wistar , Signal Transduction , Tetracycline/metabolism , Time Factors , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...